What is the dosage of Retevmo?

Retevmo is available in 6 dosages, including 120 mg Tab, 40 mg Tab, 80 mg Cap, 160 mg Tab, 80 mg Tab and 40 mg Cap

What does Retevmo treat?

Retevmo treats Carcinoma, Non-Small-Cell Lung and Thyroid Neoplasms

What is Retevmo made of?

Retevmo contains selpercatinib which is a Kinase Inhibitor

How is Retevmo administered?

Retevmo is administered as a Oral Pill

What is Retevmo mechanism of action?

Retevmo mechanism of action is P-Glycoprotein Inhibitors, Cytochrome P450 2C8 Inhibitors, Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 3A Inhibitors, Multidrug and Toxin Extrusion Transporter 1 Inhibitors or Rearranged during Transfection (RET) Inhibitors

Retevmo Prescribing & Dosing Schedule

Dosage & Administration

* Select patients for treatment with RETEVMO based on the presence of a RET gene fusion (NSCLC, thyroid, or other solid tumors) or specific RET gene mutation (MTC).
* Adult and adolescent patients 12 years of age or older:
the recommended dosage is based on weight :
* Less than 50 kg: 120 mg orally twice daily
* 50 kg or greater: 160 mg orally twice daily

* Pediatric patients 2 to less than 12 years of age:
the recommended dosage is based on body surface area :
* 0.33 to 0.65 m2: 40 mg orally three times daily
* 0.66 to 1.08 m2: 80 mg orally twice daily
* 1.09 to 1.52 m2: 120 mg orally twice daily
* ≥1.53 m2: 160 mg orally twice daily

* Reduce RETEVMO dose in patients with severe hepatic impairment.

Most viewed Retevmo resources

Enroll in Patient Savings Program

Get Your Patient on Retevmo

See your patient's specific prior authorization requirements including coverage restrictions and step therapies

Or select your Insurance from the list below:

Retevmo Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Retevmo Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Appeals

Complete Letter of Medical Necessity

Retevmo Preferred Pharmacy

Pharmacy List

Retevmo Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Lilly Cares Foundation

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

Retevmo PubMed™ News

Retevmo Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link